Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis

Objectives The negative effects of smoking on numerous cardiovascular and metabolic diseases have been widely acknowledged. However, the potential effect of smoking cessation is relatively unelucidated. The objective of this study is to explore whether the prevalence of non-alcoholic fatty liver dis...

Full description

Bibliographic Details
Main Authors: Qinghua Yang, Guang Ji, Shengan Zhang, Zhidong Liu, Zichun Hu, Wenjun Zhou, Yanqi Dang
Format: Article
Language:English
Published: BMJ Publishing Group 2023-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/12/e074216.full
_version_ 1797369775836364800
author Qinghua Yang
Guang Ji
Shengan Zhang
Zhidong Liu
Zichun Hu
Wenjun Zhou
Yanqi Dang
author_facet Qinghua Yang
Guang Ji
Shengan Zhang
Zhidong Liu
Zichun Hu
Wenjun Zhou
Yanqi Dang
author_sort Qinghua Yang
collection DOAJ
description Objectives The negative effects of smoking on numerous cardiovascular and metabolic diseases have been widely acknowledged. However, the potential effect of smoking cessation is relatively unelucidated. The objective of this study is to explore whether the prevalence of non-alcoholic fatty liver disease (NAFLD) in former smokers differs from the prevalence in current smokers.Design Systematic review and meta-analysis.Data sources Four databases, that is, PubMed, Web of Science, Journal@Ovid and Scopus were searched from inception to 31 January 2023.Eligibility criteria Population-based cross-sectional studies, including the baseline data of cohort studies with identified NAFLD diagnostic methods, and smoking status (current smoker or former smoker) of participants were included.Data extraction and synthesis Two reviewers independently extracted the data including cigarette smoking status, country/region of studies, NAFLD diagnostic methods, sex, the average age and body mass index (BMI) of NAFLD participants and assessed the risk of bias with Agency for Healthcare Research and Quality (AHRQ) methodology checklist. Risk ratio (RR) of NAFLD prevalence in former smokers was pooled using the random-effects model.Results 28 studies involving 4 465 862 participants were included. Compared with current smokers, the RR of overall NAFLD prevalence in former smokers was 1.13 (95% CI: 1.08 to 1.19, prediction interval: 0.92–1.39). This result persisted after adjustment for diagnostic methods, country/region, sex, age and BMI. Sensitivity analysis and risk of bias assessment indicated a stable conclusion.Conclusions NAFLD prevalence in former smokers was at least not lower than that in current smokers and was partially related to increased BMI after smoking cessation, indicating that smoking cessation was possibly not a protective factor against NAFLD. Although the meta-analysis based on cross-sectional studies cannot conclude the causal relationships between smoking cessation and NAFLD onset, the potential onset of NAFLD associated with smoking cessation should be highlighted.PROSPERO registration number CRD42023394944.
first_indexed 2024-03-08T17:52:45Z
format Article
id doaj.art-094b117009974c5bb0ef17e13ce63a9c
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-03-08T17:52:45Z
publishDate 2023-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-094b117009974c5bb0ef17e13ce63a9c2024-01-02T06:45:08ZengBMJ Publishing GroupBMJ Open2044-60552023-12-01131210.1136/bmjopen-2023-074216Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysisQinghua Yang0Guang Ji1Shengan Zhang2Zhidong Liu3Zichun Hu4Wenjun Zhou5Yanqi Dang6Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaObjectives The negative effects of smoking on numerous cardiovascular and metabolic diseases have been widely acknowledged. However, the potential effect of smoking cessation is relatively unelucidated. The objective of this study is to explore whether the prevalence of non-alcoholic fatty liver disease (NAFLD) in former smokers differs from the prevalence in current smokers.Design Systematic review and meta-analysis.Data sources Four databases, that is, PubMed, Web of Science, Journal@Ovid and Scopus were searched from inception to 31 January 2023.Eligibility criteria Population-based cross-sectional studies, including the baseline data of cohort studies with identified NAFLD diagnostic methods, and smoking status (current smoker or former smoker) of participants were included.Data extraction and synthesis Two reviewers independently extracted the data including cigarette smoking status, country/region of studies, NAFLD diagnostic methods, sex, the average age and body mass index (BMI) of NAFLD participants and assessed the risk of bias with Agency for Healthcare Research and Quality (AHRQ) methodology checklist. Risk ratio (RR) of NAFLD prevalence in former smokers was pooled using the random-effects model.Results 28 studies involving 4 465 862 participants were included. Compared with current smokers, the RR of overall NAFLD prevalence in former smokers was 1.13 (95% CI: 1.08 to 1.19, prediction interval: 0.92–1.39). This result persisted after adjustment for diagnostic methods, country/region, sex, age and BMI. Sensitivity analysis and risk of bias assessment indicated a stable conclusion.Conclusions NAFLD prevalence in former smokers was at least not lower than that in current smokers and was partially related to increased BMI after smoking cessation, indicating that smoking cessation was possibly not a protective factor against NAFLD. Although the meta-analysis based on cross-sectional studies cannot conclude the causal relationships between smoking cessation and NAFLD onset, the potential onset of NAFLD associated with smoking cessation should be highlighted.PROSPERO registration number CRD42023394944.https://bmjopen.bmj.com/content/13/12/e074216.full
spellingShingle Qinghua Yang
Guang Ji
Shengan Zhang
Zhidong Liu
Zichun Hu
Wenjun Zhou
Yanqi Dang
Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis
BMJ Open
title Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis
title_full Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis
title_fullStr Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis
title_full_unstemmed Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis
title_short Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis
title_sort impact of smoking cessation on non alcoholic fatty liver disease prevalence a systematic review and meta analysis
url https://bmjopen.bmj.com/content/13/12/e074216.full
work_keys_str_mv AT qinghuayang impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis
AT guangji impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis
AT shenganzhang impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis
AT zhidongliu impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis
AT zichunhu impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis
AT wenjunzhou impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis
AT yanqidang impactofsmokingcessationonnonalcoholicfattyliverdiseaseprevalenceasystematicreviewandmetaanalysis